ArticlePathology oncology research : POR2023

Tumor PD-L1 expression and molecular profiling are not associated with immune checkpoint inhibitor-induced thyroid dysfunction in advanced NSCLC patients.

Adi Horesh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.